[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336358-105":59,"doc-detail-336358-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","slamf8-can-predict-prognosis-of-pan-cancer-and-the-immunotherapy-response-effectivity-of-gastric-cancer","SLAMF8 can predict prognosis of pan-cancer and the immunotherapy response effectivity of gastric cancer","","SLAMF8, an SLAMF family costimulatory receptor, is investigated for its role in pan-cancer prognosis and immunotherapy response, with a focus on gastric cancer. The study evaluates associations between SLAMF8 expression and immune microenvironment features, microsatellite instability, neoantigens, gene mutations, immune regulatory factors, immune checkpoint metrics, and molecular subtypes. Differential expression and survival analyses link higher SLAMF8 levels to worse outcomes across cancers, while gastric cancer shows improved response to PD-1 blockade with Sintilimab. Immunohistochemistry supports SLAMF8 presence across multiple tumor types.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/slamf8-can-predict-prognosis-of-pan-cancer-and-the-immunotherapy-response-effectivity-of-gastric-cancer/336358/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/slamf8-can-predict-prognosis-of-pan-cancer-and-the-immunotherapy-response-effectivity-of-gastric-cancer/336358.png","ImageObject",300,407,{"name":92,"@type":93},"Hazel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the purpose of studying SLAMF8 in this research?","Question",{"text":112,"@type":113},"To determine how SLAMF8 relates to pan-cancer prognosis and whether it can predict immunotherapy response effectiveness in gastric cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which factors were analyzed in relation to SLAMF8 across cancers?",{"text":117,"@type":113},"The study analyzes SLAMF8 correlations with immune microenvironment features, microsatellite instability, immune neoantigens, gene mutations, immune regulatory factors, immune checkpoint/TMB-related measures, and SLAMF8 immune or molecular subtypes.",{"name":119,"@type":110,"acceptedAnswer":120},"How was SLAMF8 expression validated experimentally?",{"text":121,"@type":113},"Immunohistochemistry was used to verify SLAMF8 presence across multiple tumor types, and gastric cancer samples were included for evaluation.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336358,1790322496,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},137441390410,"https://ap-avatar.wpscdn.com/avatar/2000252f4ab5702993?_k=1776741390130283984","[www.aging-us.com](www.aging-us.com) AGING 2024, Vol. 16, No. 10  \nResearch Paper  \nSLAMF8 can predict prognosis of pan-cancer and the immunotherapy response effectivity of gastric cancer  \nGuangyao Li 1, Qijiao Li2, Miaomiao Ping2, Ziying Jiao2, Xingxing Wang2, Juan Cheng2,*, Jizheng Guo2,*, Ya Cheng3,*  \n1 Department of Gastrointestinal Surgery, The Second People’s Hospital of Wuhu, Wuhu 241000, Anhui, China 2School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, Anhui, China  \n3 Department of Emergency Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei 230032, Anhui, China  \n* Equal contribution  \nCorrespondence to: Juan Cheng, Jizheng Guo, Ya Cheng; email: [juancheng@ahmu.edu.cn](juancheng@ahmu.edu.cn), [guojizheng@ahmu.edu.cn](guojizheng@ahmu.edu.cn); [2336020145@stu.ahmu.edu.cn](2336020145@stu.ahmu.edu.cn)  \nKeywords: SLAMF8, pan-cancer, biomarker, TME, immunotherapy  \nReceived: January 30, 2024 Accepted: April 19, 2024 Published: May 22, 2024  \nCopyright: © 2024 Li et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nABSTRACT  \nSLAMF8, the eighth member of the Signaling Lymphocytic Activation Molecule Family (SLAMF), functions in the regulation of the development and activity of diverse immune cells as a costimulatory receptor within the SLAMF family. Studies had revealed that SLAMF8 is expressed higher in several autoimmune inflammation diseases and tumors. Nevertheless, the connection between SLAMF8 and pan-cancer remains undisclosed. The research investigated the correlation between SLAMF8 and various factors including the immune microenvironment, microsatellite instability, immune novel antigen, gene mutation, immune regulatory factors, immune blockade TMB, and immune or molecular subtypes of SLAMF8 in verse cancer types. Immunohistochemistry was ultimately employed to validate the presence of the SLAMF8 gene in various tumor types including hepatocellular carcinoma, prostate adenocarcinoma, and kidney renal clear cell carcinoma. Furthermore, the relationship between SLAMF8 expression and the therapeutic efficacy of the PD1 blockade agent, Sintilimab, treatment in gastric cancer was validated. The result of differential analysis suggested that SLAMF8 was over-expressed in pan-cancer compared with paracancerous tissues. The analysis of survival indicated a connection between SLAMF8 and the overall prognosis in different types of cancers, where higher levels of SLAMF8 were found to be significantly linked to unfavorable outcomes in patients but favorable outcome of immunotherapy in gastric cancer. Significant correlations were observed between SLAMF8 levels and pan-cancer tumorigenesis, tumor metabolism, and immunity. As a result, SLAMF8 may become an important prognostic biomarker in the majority of tumors and a hopeful gene target for immunotherapy against gastric cancer.  \nINTRODUCTION  \nThe International Agency for Research on Cancer (IARC) disclosed that around 19.3 million new cancer cases were documented worldwide in 2020, and despite ongoing advancements in cancer treatment strategies, the outlook for cancer prognosis remained pessimistic  \n[1, 2] . Enhancing cancer management relies on the improvement of cancer diagnosis and prognosis, making it imperative to explore new biomarkers for these purposes.  \nThe eighth member of the Signaling Lymphocytic Activation Molecule Family (SLAMF), known as  \n8944  \nSLAMF8 (CD353), is a costimulatory receptor within the SLAMF family. It plays a regulatory role in the development and function of diverse immune cells, including T lymphocytes, B cells, neutrophils, dendritic cells, macrophages, and eosinophils [3, 4] . Recent studies had revealed that SLAMF8 is more highly expressed in several autoimmune inflammation diseases and tumo","cbCaidOC3TdCqKt1","https://ap.wps.com/l/cbCaidOC3TdCqKt1","pdf",4822816,21,"English","# Abstract\n# Introduction\n# Materials and Methods\n## Data sources\n## SLAMF8 expression in pan-cancer\n## Immunohistochemistry of paraffin sections","[{\"question\":\"What is the purpose of studying SLAMF8 in this research?\",\"answer\":\"To determine how SLAMF8 relates to pan-cancer prognosis and whether it can predict immunotherapy response effectiveness in gastric cancer.\"},{\"question\":\"Which factors were analyzed in relation to SLAMF8 across cancers?\",\"answer\":\"The study analyzes SLAMF8 correlations with immune microenvironment features, microsatellite instability, immune neoantigens, gene mutations, immune regulatory factors, immune checkpoint/TMB-related measures, and SLAMF8 immune or molecular subtypes.\"},{\"question\":\"How was SLAMF8 expression validated experimentally?\",\"answer\":\"Immunohistochemistry was used to verify SLAMF8 presence across multiple tumor types, and gastric cancer samples were included for evaluation.\"}]","SLAMF8 can predict prognosis of pan-cancer and the immunotherapy response effectivity of gastric cancer | PDF",1790014693,53,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/590fc628a1e80896119d0b12c2b5bf45.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cdceba3fbbf8544d240e42c9c7eac228.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6e878c5f6171a98637351069866c4062.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7af9afbca3f622644e5cedf17bb3e5ac.webp",980,1268]